NCT01949324: A trial that was reported late by Neurotech Pharmaceuticals
This trial has reported, although it was 1826 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01949324 |
|---|---|
| Title | A Phase 2 Multicenter Randomized Clinical Trial of Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | April 30, 2014 |
| Completion date | April 14, 2017 |
| Required reporting date | April 14, 2020, midnight |
| Actual reporting date | April 14, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 1826 |